April 15, 2024

Mp05-05 Darolutamide Mediated Pufa/Mufa Ratio to Mediate Lipid Peroxidation Through Ar-Srebp1-Fasn Axis and Synergizeds With Ferroptosis Inducers in Prostate Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

You have accessJournal of UrologyProstate Cancer: Basic Research the National Natural Science Foundation of China (No:81974395, No:82173036) © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e44 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Li BingHeng More articles by this author Hai Huang More articles by this author Expand All Advertisement PDF downloadLoading ...

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

BingHeng et al. (Mon,) studied this question.

www.synapsesocial.com/papers/68e6f174b6db64358766c673 — DOI: https://doi.org/10.1097/01.ju.0001008740.27639.cc.05

Authors

Li BingHeng

Hai Huang

Journals

The Journal of Urology

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Mp05-05 Darolutamide Mediated Pufa/Mufa Ratio to Mediate Lipid Peroxidation Through Ar-Srebp1-Fasn Axis and Synergizeds With Ferroptosis Inducers in Prostate Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion